Agena Bioscience
Booth number: Z6.C49
www.agenabio.com
About us
Agena Bioscience empowers research laboratories worldwide to deliver scalable targeted genomic data. Our advanced platforms deliver timely molecular insights in the areas of mutation profiling, liquid biopsy, pharmacogenetics, and more. Agena offers the MassARRAY System, an open platform that provides researchers with insights through a highly multiplexed solution.
These are Agena Bioscience focus areas: Gene expression, SNP genotyping, Sample quantitation, Copy number variation, Analytical instruments, Lab equipment, Life science research, Applied testing, Pharmaceutical research, Liquid Biopsy, Pharmacogenomics, Mutation Profiling, Sample Integrity, Specimen Validity, Hereditary Genetics, Methylation, Chimerism, Blood Typing und Custom Assays.
-thumb.webp)
Address
Gasstr. 18, House 5
22761 Hamburg
Germany
E-mail: katja.zornbach@agenabio.com
Phone: +49 40 899676-0
Internet: www.agenabio.com
Contact person:
Hicham EL Mahmoudi
Manager Partnerships & Distributions
E-mail: hicham.elmahmoudi@agenabio.com
Products & Services
These are Agena Bioscience focus areas: Gene expression, SNP genotyping, Sample quantitation, Copy number variation, Analytical instruments, Lab equipment, Life science research, Applied testing, Pharmaceutical research, Liquid Biopsy, Pharmacogenomics, Mutation Profiling, Sample Integrity, Specimen Validity, Hereditary Genetics, Methylation, Chimerism, Blood Typing und Custom Assays.
Pharmacogenetics
Whether you’re just getting started or already have a well-established program, Agena’s PGx solutions deliver accuracy while minimizing costs. Simultaneous genotyping and copy number detection enable labs to implement a single, comprehensive PGx workflow.
Mutation Profiling
Precision oncology research requires somatic variant detection that is rapid and low-cost. Reliable detection of low abundance somatic mutations can be challenging due to limited quantity & poor quality of the specimens. Several technologies require specimens with high tumor content and generally reject as many as 20% of the samples due to low tumor fraction and DNA yield.
With the MassARRAY® System’s single day workflow and multiplexed chemistry, you can get information for variants quickly and at a low cost. iPLEX® HS chemistry enables detection of relevant variants from low sample input.
Sample Integrity
Studies estimate 1 in every 200 samples is misidentified, potentially causing incorrect results. Labs implement rigorous quality systems to ensure chain of custody for specimens. However, specimen mishandling may occur at various steps, and these mistakes can result in incorrect care, damaging a lab’s reputation. Labs need robust sample identity tracking to prevent errors and ensure the results match the specimen.
